Literature DB >> 17351755

Changes in the treatment of acute psychosis in a German public hospital from 1998 to 2004.

Tiemo Wessels1, Dandy Grünler, Christa Bunk, Michael Specka, Markus Gastpar, Norbert Scherbaum, Eugen Davids.   

Abstract

INTRODUCTION: The aim of our study was to investigate antipsychotic treatment strategies in acute schizophrenic episodes in a German university hospital.
METHODS: Documented pharmacological procedures in the first six weeks of acute episodes of schizophrenia in the years 1998 (n = 108), 2001 (n = 92), and 2004 (n = 94) were analyzed. Inclusion criteria were: admission voluntary and involuntary as inpatient to our acute ward with a diagnosis of F20x according to ICD 10.
RESULTS: Atypical antipsychotics (AAP) were significant more frequently used in the first week of treatment in 2001 and 2004 compared to the year 1998. Switching to AAP occurred significantly earlier in 2001 and 2004 (after 7.6 +/- 7 days in 1998, 3.5 +/- 5 days in 2001 and 2.3 +/- 5 days in 2004; P < 0.002). In all three years prescription of high potent typical antipsychotics decreased during the first six weeks of treatment. Involuntary treatment (P < 0.001) and age (P = 0.001) were significantly correlated to initial prescription of AAP. Involuntary admitted patients received more often a combination of high-potent conventional high potent typical neuroleptics and AAP (48% vs. 24%, P = 0.007).
CONCLUSION: Second generation atypicals are used more frequently according to current guidelines and switching from conventional medications occurs earlier.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17351755     DOI: 10.1007/s11126-006-9030-y

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  29 in total

1.  Antipsychotic prescribing practices in Connecticut's public mental health system: rates of changing medications and prescribing styles.

Authors:  Nancy H Covell; Carlos T Jackson; Arthur C Evans; Susan M Essock
Journal:  Schizophr Bull       Date:  2002       Impact factor: 9.306

2.  Superior efficacy of olanzapine over haloperidol: analysis of patients with schizophrenia from a multicenter international trial.

Authors:  J C Gomez; A M Crawford
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

3.  A comparison of the effects of quetiapine ('seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group.

Authors:  R A Emsley; J Raniwalla; P J Bailey; A M Jones
Journal:  Int Clin Psychopharmacol       Date:  2000-05       Impact factor: 1.659

4.  Schizophrenia practice guidelines: international survey and comparison.

Authors:  Wolfgang Gaebel; Stefan Weinmann; Norman Sartorius; Wolfgang Rutz; John S McIntyre
Journal:  Br J Psychiatry       Date:  2005-09       Impact factor: 9.319

5.  Psychotropic drug prescription in a psychiatric university hospital.

Authors:  P Voirol; P A Robert; P Meister; L Oros; P Baumann
Journal:  Pharmacopsychiatry       Date:  1999-01       Impact factor: 5.788

6.  Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.

Authors:  Rahul Ganguly; Jeffrey A Kotzan; L Stephen Miller; Klugh Kennedy; Bradley C Martin
Journal:  J Clin Psychiatry       Date:  2004-10       Impact factor: 4.384

7.  Switching antipsychotics in inpatient schizophrenia care: predictors and outcomes.

Authors:  Stefan Weinmann; Birgit Janssen; Wolfgang Gaebel
Journal:  J Clin Psychiatry       Date:  2004-08       Impact factor: 4.384

8.  Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia.

Authors:  Peter J Weiden; George M Simpson; Steven G Potkin; Richard L O'Sullivan
Journal:  J Clin Psychiatry       Date:  2003-05       Impact factor: 4.384

9.  Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.

Authors:  George M Simpson; Ira D Glick; Peter J Weiden; Steven J Romano; Cynthia O Siu
Journal:  Am J Psychiatry       Date:  2004-10       Impact factor: 18.112

10.  Trends in the rate and type of antipsychotic medications prescribed to persons with schizophrenia.

Authors:  Aileen B Rothbard; Eri Kuno; Kathy Foley
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

View more
  1 in total

1.  Off-label use of sodium valproate for schizophrenia.

Authors:  Einav Horowitz; Lisa Carroll Bergman; Charna Ashkenazy; Irit Moscona-Hurvitz; Haya Grinvald-Fogel; Racheli Magnezi
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.